AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $37.73M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| NTD | Becoming a substantial holder | 18/04/18 | ||
| NTD | Half Year Results - Investor Presentation | 27/02/18 | ||
| NTD | Half Year Results - Media Release | 27/02/18 | ||
| NTD | Dividend/Distribution - NTD | 27/02/18 | ||
| NTD | Appendix 4D and Half Year Financial Report | PRICE SENSITIVE | 27/02/18 | |
| NTD Becoming a substantial holder | |||
| 18/04/18 | |||
| NTD Half Year Results - Investor Presentation | |||
| 27/02/18 | |||
| NTD Half Year Results - Media Release | |||
| 27/02/18 | |||
| NTD Dividend/Distribution - NTD | |||
| 27/02/18 | |||
| NTD Appendix 4D and Half Year Financial Report | |||
| 27/02/18 | PRICE SENSITIVE | ||
